IntrinsicIntrinsic

Other Events ·

Dalrada settles dispute with IBS for $20,000, terminating $1.16M credit facility

DFCODalrada Financial Corp

Dalrada Technology Group settled a commercial dispute with IBS Equity Fund III and IBS Private Credit Fund IV for a lump sum of $20,000. The settlement resolves IBS's prior demand for approximately $1,162,246 in fees and charges related to defaulted Financing Documents, including a Master Performance Standby Letter of Credit and a Master Credit Agreement. Upon closing on October 2, 2026, all financing documents were terminated, obligations discharged, and liens released. IBS confirmed it holds no equity or warrants in the company. Dalrada Technology Group operates in the technology sector.

More from Dalrada Financial Corp

Explore DFCO